Onchocerciasis

Onchocerciasis or river blindness is the world's second leading infectious cause of blindness. It is caused by Onchocerca volvulus, a Parasitic worm that can live for up to fifteen years in the human body. (From the Wikpedia article Onchocerciasis.)

Download PDF containing detailed information.

Recent Publications on Onchocerciasis:
Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure. Human onchocerciasis, caused by the filarial nematode Onchocerca volvulus,...	11th November, 2009	Veterinary Parasitology Group, Liverpool School of Tropical Medicine and	PLoS Negl Trop Dis. 2009 Nov 10;3(11):e544. DOI Direct Link
Neglected tropical diseases in Brazil. Poverty is intrinsically related to the incidence of Neglected Tropical...	7th November, 2009	SES, Instituto de Infectologia Emilio Ribas, Sao Paulo, SP, Brasil.	Rev Inst Med Trop Sao Paulo. 2009 Sep-Oct;51(5):247-53.
Controlling and eliminating neglected diseases in Latin America and the Caribbean. This paper analyzes the rationale for, and costs associated with, the...	6th November, 2009	Bitran and Associates in Santiago, Chile.	Health Aff (Millwood). 2009 Nov-Dec;28(6):1707-19. DOI Direct Link
Laboratory diagnosis of infections due to blood and tissue parasites. Microscopy remains the cornerstone of the laboratory diagnosis of...	3rd November, 2009	Division of Clinical Microbiology, Hilton 470, Mayo Clinic, Rochester, MN	Clin Infect Dis. 2009 Oct 1;49(7):1103-8. DOI Direct Link
Onchocerciasis (river blindness). Report from the eighteenth InterAmerican Conference on Onchocerciasis, November 2008. la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations Identification of drug resistance before it becomes a public health...	15th October, 2009		Wkly Epidemiol Rec. 2009 Sep 18;84(38):385-9.
→View more research publications.

Press Releases About Onchocerciasis:
River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries	21st November, 2009	American Society of Tropical Medicine and Hygiene	WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -- A regional initiative launched in the 1990s to eliminate onchocerciasis (river blindness) in the Americas has substantially reduced the prevalence of the

Onchocerciasis Clinical Trials:
Study Evaluating Orally Administered Moxidectin in Subjects With Onchocerca Volvulus Infection

Onchocerciasis Patents:
US Patent No.	Title
7368527	HADDE71 polypeptides
7411051	Antibodies to HDPPA04 polypeptide
7414062	Triazaspiro compounds useful for treating or preventing pain
7416723	Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
7417121	Human G-protein coupled receptor, HGPRBMY39
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Onchocerciasis scientists - we have details of around 366 individuals working on Onchocerciasis .